No Comments
     

International Congress On Hematologic Malignancies 2024. Advancing oncology nursing™ thursday, march 27, 2025 new location! The annual international congress on hematologic malignancies ®:


International Congress On Hematologic Malignancies 2024

The 2024 meeting promises to be a dynamic and informative event. The nccn 2024 annual congress:

Expert Faculty Focus On Updates From Recent Congresses And The Latest Clinically Relevant Data.

Global cancer care in older adults:

Lymphoma, Leukemia &Amp; Myeloma Congress 2024.

Soho is the premier meeting that focuses specifically on new advances and practical clinical applications in the field of hematologic malignancies.

The Ash Meeting On Hematologic Malignancies (Mhm) Features The Top Experts In The Field, Comprehensive Clinical Content, And The Opportunity To Interact With Colleagues In An Intimate, Small Group Setting With No Competing Sessions.

Images References :

Recorded Presentations Will Be Available On The Nccn Continuing Educational Portal, Education.nccn.org, In Late June 2024.

Lymphoma, leukemia & myeloma congress 2024.

28Th Annual International Congress On Hematologic Malignancies 2024.

Global cancer care in older adults:

Beigene Has Unveiled A New Analysis Comparing The Efficacy Of Brukinsa® (Zanubrutinib) To Acalabrutinib In Patients With Relapsed Or Refractory (R/R) Chronic Lymphocytic Leukemia (Cll), Utilizing A Matching Adjusted Indirect Comparison (Maic) Based On Data From The Phase 3 Alpine And Phase 3 Ascend Trials.